Bivatuzumab
Bivatuzumab (previously BIWA 4) is a humanized monoclonal antibody against CD44 v6. It is officially described as "immunoglobulin G1 (human-mouse monoclonal BIWA4 γ1-chain anti-human antigen CD44v6), disulfide with human-mouse monoclonal BIWA4 κ-chain, dimer". Prior to 2002 it was described as targeting CD44 v8. It has been chemically linked to various radioisotopes for use in radiotherapy for, e.g. inoperable recurrent or metastatic head and neck cancer. It has also been linked to a cytotoxic drug mertansine to form bivatuzumab mertansine.
Link from a Wikipage to another Wikipage
primaryTopic
Bivatuzumab
Bivatuzumab (previously BIWA 4) is a humanized monoclonal antibody against CD44 v6. It is officially described as "immunoglobulin G1 (human-mouse monoclonal BIWA4 γ1-chain anti-human antigen CD44v6), disulfide with human-mouse monoclonal BIWA4 κ-chain, dimer". Prior to 2002 it was described as targeting CD44 v8. It has been chemically linked to various radioisotopes for use in radiotherapy for, e.g. inoperable recurrent or metastatic head and neck cancer. It has also been linked to a cytotoxic drug mertansine to form bivatuzumab mertansine.
has abstract
Bivatuzumab (previously BIWA 4 ...... o form bivatuzumab mertansine.
@en
بيفاتوزوماب هو جسم مضاد وحيد ا ...... ن ليكونا بيفاتوزوماب مرتانسين.
@ar
CAS number
214559-60-1
DrugBank
FDA UNII code
0A0Z1IJN86
Wikipage page ID
page length (characters) of wiki page
Wikipage revision ID
1,012,802,288
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChemSpiderID
none
@en
DrugBank
DB06550
@en
mab type
mab
@en
source
zu/o
@en
target
CD44 v6
@en
type
mab
@en
verifiedrevid
455,436,827
wikiPageUsesTemplate
hypernym
comment
Bivatuzumab (previously BIWA 4 ...... o form bivatuzumab mertansine.
@en
بيفاتوزوماب هو جسم مضاد وحيد ا ...... ن ليكونا بيفاتوزوماب مرتانسين.
@ar
label
Bivatuzumab
@en
بيفاتوزوماب
@ar